Cancer Insight
1 known investors
LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.
BiotechDigital HealthHealthtech
Founders & leadership
GP
George PeoplesFounder
Investors Β· 1
Competitors Β· 5
by search overlap
ADP5 shared keywordsADP provides cloud-based human capital management solutions that integrate payroll, HR, talent management, time and attendance, tax, and benefits administration for businesses globally. The company serves as a comprehensive provider of HCM software and business outsourcing services with analytics and compliance expertise.
Bridgebio5 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Lumanity5 shared keywordsLumanity provides consulting services across strategy, evidence generation, stakeholder engagement, and technology and AI to support pharmaceutical and life sciences companies in bringing medicines to patients. It helps clients identify value inflection points to inform strategic decisions in drug development and commercialization.
Consider4 shared keywordsConsider is a recruiting platform that helps talent teams source and manage candidate profiles, including a Chrome extension for adding LinkedIn profiles to talent pools in one click. It offers recruiting analytics, SSO, and two-way integrations with tools such as Greenhouse, Lever, and Salesforce.
Preqin4 shared keywordsPreqin provides private markets data, analytics, and benchmarking across private equity, venture capital, hedge funds, real estate, private credit, infrastructure, secondaries, and natural resources. Its products serve fund managers, investors, consultants, banks, and other financial professionals for fundraising, manager selection, due diligence, and performance analysis.
Companies competing with Cancer Insight for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cancer Insight do?
- LumaBridge is an oncology-focused contract research organization (CRO) that supports outsourced clinical trials, offering services such as regulatory affairs, clinical operations, data management, medical writing, and biostatistics. It serves emerging biopharma and biotech companies developing novel oncology and immunotherapy treatments.
- Who founded Cancer Insight?
- Cancer Insight was founded by George Peoples.
- Who are Cancer Insight's investors?
- Cancer Insight's investors include Summit Partners.